PNS246 EMA G-BA - A COMPARISON OF TIME LIMITATIONS OF EUROPEAN MARKETING AUTHORIZATIONS AND GERMAN ADDED BENEFIT ASSESSMENTS FOR NEW PHARMACEUTICALS.

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2146
https://www.valueinhealthjournal.com/article/S1098-3015(19)34524-3/fulltext
Title : PNS246 EMA G-BA - A COMPARISON OF TIME LIMITATIONS OF EUROPEAN MARKETING AUTHORIZATIONS AND GERMAN ADDED BENEFIT ASSESSMENTS FOR NEW PHARMACEUTICALS.
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34524-3&doi=10.1016/j.jval.2019.09.2146
First page :
Section Title :
Open access? : No
Section Order : 11862
Categories :
Tags :
Regions :
ViH Article Tags :